About Metalloreductase STEAP2
Metalloreductase STEAP2 (STEAP2) is a protein
from Homo sapiens identified by UniProt accession
Q8NFT2, 490 residues long.
MolForge cross-references it against 0 known binders and
82 disease associations.
Target properties
| Protein name | Metalloreductase STEAP2 |
| UniProt accession | Q8NFT2 |
| Gene | STEAP2 |
| Organism | Homo sapiens |
| Length | 490 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (82)
Diseases linked to this target (Open Targets).
- type 2 diabetes mellitus · score 0.44
- diastolic blood pressure · score 0.43
- pulse pressure measurement · score 0.42
- glucose measurement · score 0.40
- HbA1c measurement · score 0.32
- hemoglobin A1 measurement · score 0.30
- arterial stiffness measurement · score 0.23
- coffee consumption measurement · score 0.20
- coffee consumption · score 0.19
- type 1 diabetes mellitus · score 0.15
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q8NFT2-F1 | alphafold | PREDICTED | 88.66 | — |
Amino-acid sequence (490 residues)
MESISMMGSP KSLSETFLPN GINGIKDARK VTVGVIGSGD FAKSLTIRLI RCGYHVVIGS RNPKFASEFF PHVVDVTHHE DALTKTNIIF VAIHREHYTS LWDLRHLLVG KILIDVSNNM RINQYPESNA EYLASLFPDS LIVKGFNVVS AWALQLGPKD ASRQVYICSN NIQARQQVIE LARQLNFIPI DLGSLSSARE IENLPLRLFT LWRGPVVVAI SLATFFFLYS FVRDVIHPYA RNQQSDFYKI PIEIVNKTLP IVAITLLSLV YLAGLLAAAY QLYYGTKYRR FPPWLETWLQ CRKQLGLLSF FFAMVHVAYS LCLPMRRSER YLFLNMAYQQ VHANIENSWN EEEVWRIEMY ISFGIMSLGL LSLLAVTSIP SVSNALNWRE FSFIQSTLGY VALLISTFHV LIYGWKRAFE EEYYRFYTPP NFVLALVLPS IVILGKIILF LPCISRKLKR IKKGWEKSQF LEEGMGGTIP HVSPERVTVM
Explore Metalloreductase STEAP2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets